DFO low-dose therapy.
Di Iorio
B
B
Terracciano
V
V
D000535:Aluminum / Q000009:adverse effects; D001847:Bone Diseases / Q000139:chemically induced / Q000175:diagnosis; D003676:Deferoxamine / Q000008:administration & dosage* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D006801:Humans
D000535:Aluminum; D003676:Deferoxamine